Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of D-Glutamate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 known ✓ | P39086 | 1/20 | 0.60 |
| ▸ | GRIA1 known ✓ | P42261 | 1/20 | 0.60 |
| ▸ | GRIA2 known ✓ | P42262 | 1/20 | 0.60 |
| ▸ | GRIA3 known ✓ | P42263 | 1/20 | 0.60 |
| ▸ | GRIA4 known ✓ | P48058 | 1/20 | 0.60 |
| ▸ | GRIN2A known ✓ | Q12879 | 1/20 | 0.60 |
| ▸ | GRIK2 known ✓ | Q13002 | 1/20 | 0.60 |
| ▸ | GRIK3 known ✓ | Q13003 | 1/20 | 0.60 |
| ▸ | GRIK5 known ✓ | Q16478 | 1/20 | 0.60 |
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.43 |
| ▸ | SLC6A4 known ✓ | P31645 | 1/20 | 0.43 |
| ▸ | SLC6A3 known ✓ | Q01959 | 1/20 | 0.43 |
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.43 |
| ▸ | DPP4 known ✓ | P27487 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.60 |
| ▸ | GRM8 | O00222 | 1/20 | 0.60 |
| ▸ | GRM6 | O15303 | 1/20 | 0.60 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.60 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.60 |
| ▸ | GSR | P00390 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| D-Glutamate SCHEMBL3781140 | 1.00 | CYP1A2 (0.60) | CYP1A2GRM8GRM6GRIN2DGRIN3B | |
| D-Glutamate SCHEMBL23828179 | 1.00 | CYP1A2 (0.60) | CYP1A2GRM8GRM6GRIN2DGRIN3B | |
| D-Glutamate SCHEMBL16336 | 0.98 | CYP1A2 (0.62) | CYP1A2GRM8GRM6GRIN2DGRIN3B | |
| D-Glutamate SCHEMBL541430 | 0.98 | CYP1A2 (0.62) | CYP1A2GRM8GRM6GRIN2DGRIN3B | |
| D-Glutamate SCHEMBL1782280 | 0.98 | CYP1A2 (0.62) | CYP1A2GRM8GRM6GRIN2DGRIN3B | |
| D-Glutamate SCHEMBL27981176 | 0.98 | CYP1A2 (0.62) | CYP1A2GRM8GRM6GRIN2DGRIN3B | |
| D-Glutamate SCHEMBL1532402 | 0.98 | CYP1A2 (0.62) | CYP1A2GRM8GRM6GRIN2DGRIN3B | |
| D-Glutamate SCHEMBL9646845 | 0.95 | CYP1A2 (0.60) | CYP1A2GRM8GRM6GRIN2DGRIN3B | |
| D-Glutamate SCHEMBL9650176 | 0.95 | CYP1A2 (0.60) | CYP1A2GRM8GRM6GRIN2DGRIN3B | |
| D-Glutamate SCHEMBL3882453 | 0.95 | CYP1A2 (0.60) | CYP1A2GRM8GRM6GRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 650 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250288624-A1 | LONG-TERM STABILIZATION, FORMULATION AND TABLETING OF LIVE MICROBIAL CELLS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2025-09-18 | — | — | US | claimed |
| US-12359164-B2 | Process for producing cell culture media | MERCK PATENT GMBH (DE) | 2025-07-15 | — | — | US | claimed |
| CN-119351219-A | Schizochytrium limacinum mutant strain for producing eicosapentaenoic acid, and mutagenesis method and application thereof | 江南大学 | 2025-01-24 | — | — | CN | claimed |
| WO-2024232927-A9 | LONG-TERM STABILIZATION, FORMULATION AND TABLETING OF LIVE MICROBIAL CELLS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2025-01-23 | — | — | WO | claimed |
| WO-2024232927-A2 | LONG-TERM STABILIZATION, FORMULATION AND TABLETING OF LIVE MICROBIAL CELLS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2024-11-14 | — | — | WO | claimed |
| EP-4455263-A1 | COMPOSITION FOR CULTURING ANIMAL CELLS | AJINOMOTO CO., INC. (JP) | 2024-10-30 | — | — | EP | claimed |
| US-20240344021-A1 | Composition for Culturing Animal Cells | AJINOMOTO CO., INC. (JP) | 2024-10-17 | — | — | US | claimed |
| CN-116649557-B | Microcrystalline monosodium glutamate and preparation method and application thereof | 廊坊梅花生物技术开发有限公司 | 2024-07-16 | — | — | CN | claimed |
| CN-117821285-A | Streptomyces producing natamycin and fermentation method and application thereof | 成都新朝阳作物科学股份有限公司 | 2024-04-05 | — | — | CN | claimed |
| CN-116649557-A | Microcrystalline monosodium glutamate and preparation method and application thereof | 廊坊梅花生物技术开发有限公司 | 2023-08-29 | — | — | CN | claimed |
| US-20110123671-A1 | ADDITIVE FOR LIVESTOCK FEED AND FEED COMPOSITION FOR LIVESTOCK | AJINOMOTO CO., INC. (JP) | 2011-05-26 | — | — | US | claimed |
| EP-2314172-A1 | LIVESTOCK FEED ADDITIVE AND LIVESTOCK FEED COMPOSITION | Ajinomoto Co., Inc. (JP) | 2011-04-27 | — | — | EP | claimed |
| US-20100094048-A1 | METHOD OF PRODUCING ALPHA-FORM GLUTAMIC ACID CRYSTALS | AJINOMOTO CO., INC. (JP) | 2010-04-15 | — | — | US | claimed |
| EP-2163539-A1 | METHOD FOR PRECIPITATING alpha-CRYSTALS OF GLUTAMIC ACID | Ajinomoto Co., Inc. (JP) | 2010-03-17 | — | — | EP | claimed |
| EP-2139988-A1 | CARDIOMYOCYTES AND METHODS OF PRODUCING AND PURIFYING CARDIOMYOCYTES | California Stem Cell, Inc. (US) | 2010-01-06 | — | — | EP | claimed |
| US-20090291886-A1 | TRANSMUCOSAL DELIVERY OF PEPTIDES AND PROTEINS | AMYLIN PHARMACEUTICALS, INC. (US) | 2009-11-26 | — | — | US | claimed |
| WO-2008112323-A1 | CARDIOMYOCYTES AND METHODS OF PRODUCING AND PURIFYING CARDIOMYOCYTES | CALIFORNIA STEM CELL, INC. (US) | 2008-09-18 | — | — | WO | claimed |
| CN-101060859-A | Cold storage temperature stable influenza vaccine compositions | MEDIMMUNE VACCINES INC (US) | 2007-10-24 | — | — | CN | claimed |
| US-4035513-A | COSMETICS | SHISEIDO CO., LTD. (JA) | 1977-07-12 | — | — | US | claimed |
| US-3981980-A | Radiopharmaceuticals for cholescintigraphy | The Council of the Institute of Medical and Veterinary Science (AU) | 1976-09-21 | — | — | US | claimed |